Can anyone take rapamycin?
Rapamycin is a powerful drug with serious side effects, including reduced immune function and blood sugar disturbances, and is not suitable for independent use outside medical supervision.
Rapamycin is a powerful drug that suppresses the immune system. This effect is so strong and so well documented that it forms the basis of its use in organ transplantation: the body must not reject the new organ. But that same mechanism means that resistance to infections decreases, and in people with an active infection the drug is therefore avoided as much as possible in clinical practice.
In addition to its effect on the immune system, rapamycin can disrupt blood sugar regulation. The drug can cause temporarily elevated blood sugar levels, reduced insulin sensitivity and loss of glucose tolerance, a condition sometimes referred to as 'pseudo-diabetes'. These are well-known side effects, not rare exceptions.
Rapamycin and related compounds have been studied and approved for specific medical situations. The analogue temsirolimus has gone through phase III studies for renal cell carcinoma and is used in certain types of cancer. In heart transplant patients with a history of cancer, rapamycin as an immunosuppressant appears to show some promise, but the evidence for this is limited and based on small studies. In a specific, genetically determined form of epilepsy in which the mTOR signalling pathway is disrupted, a rapamycin-like agent may be considered as part of a personalised treatment. All of these applications take place under medical supervision, in selected patients.
Rapamycin is therefore explicitly not a drug for the general population. The combination of immunosuppression, increased infection risk and disruption of blood sugar regulation means that use outside a medical context with physician oversight carries unacceptable risks for virtually everyone. People who consider rapamycin for supposed anti-ageing effects do so at their own risk and outside the framework of existing clinical evidence.
The claims are based on a limited set of studies, including clinical observations in transplant patients, phase III cancer research and smaller studies in specific patient groups. No large RCTs are available on rapamycin in healthy individuals for preventive purposes.
Will a doctor prescribe rapamycin?
Most doctors will not prescribe rapamycin to healthy people to slow ageing, simply because the evidence for doing so is still lacking. For certain rare conditions a specialist may consider it off-label, but always with a careful weighing of the risks.
Is rapamycin found in food, or can you get it naturally through your diet?
Rapamycin is not found in food and cannot be obtained through your diet. It is a medicine used only under medical supervision, due to the real risk of immune suppression.
What do we know about rapamycin as an anti-ageing agent in humans?
Rapamycin shows early positive signals in humans for immune function and skin, but long-term safety is unknown and side effects such as infections and unfavourable blood lipids are a real risk. Use outside a clinical trial is premature.
Does rapamycin help people live longer in good health?
Rapamycin works in mice, but whether it also leads to a longer and healthier life in humans has not yet been demonstrated. Side effects are real, long-term data in healthy people are absent, and use outside a clinical context cannot currently be justified.
Does rapamycin improve skin aging?
Topical rapamycin showed promising signs for skin ageing in a small study, but the evidence is still too thin to justify self-application.
Can rapamycin reverse or prevent grey hair?
Rapamycin shows interesting effects on pigmentation in the lab and in a rare hereditary disease, but there is no evidence whatsoever that it reverses or prevents grey hair in healthy people.